                         SEQUENCE LISTING

<110>  INSTITUT PASTEUR
       INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
       CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
 
<120>  PEPTIDOMIMETICS, METHOD OF SYNTHESIS AND USES THEREOF

<130>  B12410A AD/AFL/KN

<140>  PCT/EPXXXX/XXXXXX
<141>  2018-12-11

<150>  EP 17306746.3 
<151>  2017-12-11

<160>  10    

<170>  PatentIn version 3.5

<210>  1
<211>  40
<212>  PRT
<213>  artificial

<220>
<223>  RI-MUB40 synthetic sequence with D amino acids


<220>
<221>  MISC_FEATURE
<222>  (1)..(40)
<223>  All amino acid residues are D amino acids

<400>  1

Phe Ile Val Thr Tyr Phe Gln Asp Asn Thr Asp Asp Asn Asp Phe Lys 
1               5                   10                  15      


Glu Gly Ala Pro Phe Asn Asp Lys Phe Leu Glu Tyr Gly Asp Gly Glu 
            20                  25                  30          


Phe Lys Lys Ile Gly Glu Ala Thr 
        35                  40  


<210>  2
<211>  41
<212>  PRT
<213>  artificial

<220>
<223>  RI-MUB40 synthetic sequence with D amino acids, with Cysteine at 
       N terminal extremity


<220>
<221>  MISC_FEATURE
<222>  (1)..(40)
<223>  All amino acid residues are D amino acids

<400>  2

Cys Phe Ile Val Thr Tyr Phe Gln Asp Asn Thr Asp Asp Asn Asp Phe 
1               5                   10                  15      


Lys Glu Gly Ala Pro Phe Asn Asp Lys Phe Leu Glu Tyr Gly Asp Gly 
            20                  25                  30          


Glu Phe Lys Lys Ile Gly Glu Ala Thr 
        35                  40      


<210>  3
<211>  41
<212>  PRT
<213>  artificial

<220>
<223>  MUB40-1 probe with Cysteine at N-terminal extremity

<400>  3

Cys Thr Ala Glu Gly Ile Lys Lys Phe Glu Gly Asp Gly Tyr Glu Leu 
1               5                   10                  15      


Phe Lys Asp Asn Phe Pro Ala Gly Glu Lys Phe Asp Asn Asp Asp Thr 
            20                  25                  30          


Asn Asp Gln Phe Tyr Thr Val Ile Phe 
        35                  40      


<210>  4
<211>  41
<212>  PRT
<213>  artificial

<220>
<223>  MUB40-2 probe with Cysteine at N-terminal extremity

<400>  4

Cys Gly Tyr Thr Asp Glu Thr Ile Pro Tyr Ser Thr Ala Glu Gly Ile 
1               5                   10                  15      


Lys Lys Phe Glu Gly Asp Gly Tyr Glu Leu Phe Lys Asp Asn Phe Pro 
            20                  25                  30          


Ala Gly Glu Lys Phe Asp Asn Asp Asp 
        35                  40      


<210>  5
<211>  41
<212>  PRT
<213>  artificial

<220>
<223>  MUB40-3 probe with Cysteine at N terminal extremity

<400>  5

Cys Asp Gln Met Leu Arg Gln Asp Asp Leu Asp Gly Tyr Thr Asp Glu 
1               5                   10                  15      


Thr Ile Pro Tyr Ser Thr Ala Glu Gly Ile Lys Lys Phe Glu Gly Asp 
            20                  25                  30          


Gly Tyr Glu Leu Phe Lys Asp Asn Phe 
        35                  40      


<210>  6
<211>  41
<212>  PRT
<213>  artificial

<220>
<223>  MUB40-4 probe with Cysteine at N terminal extremity

<400>  6

Cys Val His Val Gln Tyr Ile Asp Gly Glu Thr Asp Gln Met Leu Arg 
1               5                   10                  15      


Gln Asp Asp Leu Asp Gly Tyr Thr Asp Glu Thr Ile Pro Tyr Ser Thr 
            20                  25                  30          


Ala Glu Gly Ile Lys Lys Phe Glu Gly 
        35                  40      


<210>  7
<211>  40
<212>  PRT
<213>  artificial

<220>
<223>  MUB40-1 probe sequence without Cysteine at N terminal extremity

<400>  7

Thr Ala Glu Gly Ile Lys Lys Phe Glu Gly Asp Gly Tyr Glu Leu Phe 
1               5                   10                  15      


Lys Asp Asn Phe Pro Ala Gly Glu Lys Phe Asp Asn Asp Asp Thr Asn 
            20                  25                  30          


Asp Gln Phe Tyr Thr Val Ile Phe 
        35                  40  


<210>  8
<211>  40
<212>  PRT
<213>  artificial

<220>
<223>  MUB40-2 probe without Cysteine at N terminal extremity

<400>  8

Gly Tyr Thr Asp Glu Thr Ile Pro Tyr Ser Thr Ala Glu Gly Ile Lys 
1               5                   10                  15      


Lys Phe Glu Gly Asp Gly Tyr Glu Leu Phe Lys Asp Asn Phe Pro Ala 
            20                  25                  30          


Gly Glu Lys Phe Asp Asn Asp Asp 
        35                  40  


<210>  9
<211>  40
<212>  PRT
<213>  artificial

<220>
<223>  MUB40-3 probe without Cysteine at N-terminal extremity

<400>  9

Asp Gln Met Leu Arg Gln Asp Asp Leu Asp Gly Tyr Thr Asp Glu Thr 
1               5                   10                  15      


Ile Pro Tyr Ser Thr Ala Glu Gly Ile Lys Lys Phe Glu Gly Asp Gly 
            20                  25                  30          


Tyr Glu Leu Phe Lys Asp Asn Phe 
        35                  40  


<210>  10
<211>  40
<212>  PRT
<213>  artificial

<220>
<223>  MUB40-4 probe without Cysteine at N terminal extremity

<400>  10

Val His Val Gln Tyr Ile Asp Gly Glu Thr Asp Gln Met Leu Arg Gln 
1               5                   10                  15      


Asp Asp Leu Asp Gly Tyr Thr Asp Glu Thr Ile Pro Tyr Ser Thr Ala 
            20                  25                  30          


Glu Gly Ile Lys Lys Phe Glu Gly 
        35                  40  


